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Abstract
Background: Body iron status has been implicated in atherosclerotic cardiovascular disease. The main hypothesis
is that high iron status is associated with increased risk of atherosclerosis. We investigated the potential role of iron
as an additional risk factor promoting atherosclerosis among beta-thalassemic patients.
Methods: In this cross-sectional study, the liver iron load was assessed by quantitative T2* MRI technique and
intima-media thickness (IMT) of the common carotid artery by high-resolution ultrasound among 119 patients (62
male, 57 female) with beta-thalassemia (major and intermediate) whose age ranged from 10 to 50 years with a
mean of 25.6 years. The patients were divided into three groups according to the severity of iron loading, obtained
by T2*MRI technique: group I (normal), group II (mild) and group III (moderate and severe) iron load.
For elimination of the effect of age on carotid IMT values, the patients also were divided into four age groups
(10-19 y, 20-29 y, 30-39 y and 40-50 y). Mean carotid IMT based on the severity of iron loading were compared at
different age groups, using one way ANOVA analysis for assessing the effect of iron loading on carotid IMT.
Pearson’s coefficient of correlation were used to assess the degree of correlation between studied variables (liver
T2*, IMT, age).
Results: There were significant differences in mean carotid IMT based on the severity of iron loading at different
age groups, with P = 0.003 at 20-29 y, P = 0.006 at 30-39 y and p = 0.037 at 40-50 y. Age (p = 0.001) and liver T2*
(p = 0.003) had significant correlation with mean carotid IMT independently.
At the age group of 10-19 years, there were not significant differences in mean carotid IMT based on the liver iron
loading (p = 0.661).
No significant differences also are seen in mean carotid IMT between male and female (p = 0.41).
Conclusions: This study identified a relationship between body iron status and carotid IMT. This relationship
support to the hypothesis of a link between body iron load and atherosclerosis.
Background
Thalassemia is considered the most common genetic
d i s o r d e rw o r l d w i d e[ 1 ] .I ti sr e s u l tf r o mad e f e c ti nt h e
synthesis of one or more of the subunits of hemoglobin.
In b-thalassemia, the b-chains of hemoglobin have a
normal structure but are produced in reduced or
undetectable amounts, resulting in excess of a-chains,
which are unstable and precipitate to form intracellular
inclusion bodies. This excessive intracellular deposition
of a-chain material is responsible for peripheral hemoly-
sis of the erythrocytes [2-4]. Conventional treatment of
the patients with b-thalassemia major is repeated blood
transfusions.
Repeated blood transfusions and peripheral hemolysis
leads to iron overload initially in reticulo-endothelial
system and secondary to all parenchymal organs, mainly
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toxic effects [5].
Accumulation of iron in excess of physiologic require-
ments has been implicated in risk of cardiovascular dis-
ease, because of the catalytic role of iron in free radical
reactions, cause oxidative stresses on vessel wall [6-8].
Increased common carotid IMT is a marker of early
atherosclerosis and has been associated with cardiovas-
cular risk and risk of coronary artery disease events
[9,10].
First, Sullivan in 1981 formulated the iron-heart
hypothesis of atherosclerotic cardiovascular disease.
According to this hypothesis, the loss of iron with men-
struation explains the lower risk of coronary heart dis-
ease(CHD) in premenopausal women compared with
men and postmenopausal women [11].
This, accompanied by the observation that hysterect-
omy without oophorectomy was associated with an
increased CHD risk [12,13].
Strong epidemiological evidence is available that iron
is an important factor in the process of atherosclerosis.
But some studies do not support the role of iron as a
potent risk factor in CHD and the role of iron in pro-
motion of atherogenesis remains controversial [13,14].
An explanation for these discrepant results may lie in
the limitations of the different markers that were used
for iron load assessing, for example, serum iron and
transferrin saturation are affected by inflammation and
diurnal variation and serum ferritin levels is affected by
factors, such as chronic inflammatory and Infectious dis-
ease, hematological and other malignancies and liver
dysfunction [5,15].
Therefore, it is quite possible that the levels of serum
ferritin are influenced by inflammation independently of
iron stores [16,17].
This may explain the failure of some previous studies
find an association between ferritin and CHD.
The liver iron concentration (LIC) is a reliable indica-
tor of total body iron stores in thalassemic patients [18].
MRI measures the LIC indirectly by detecting the para-
magnetic effect produced by iron deposition. Deposition
of iron in the liver increases the magnetic field heteroge-
neities, resulting in a decreased T2* relaxation value of
the liver that leads to a decline in liver MRI signal, pro-
portionally to the amount of the LIC [19,20].
This method (T2*MRI) is a quantitative, non-invasive,
accurate, widely available and reproducible method for
estimating iron over load in different tissues [21,22].
T h e r e f o r e ,i nt h i ss t u d yw ew e r eu s e df r o mq u a n t i t a -
tive T2*MRI technique, for estimation of the liver iron
stores (as the indicator of body iron load).
The purpose of this study was to evaluate the role of
iron as a potent risk factor in early atherosclerosis.
Methods
Subjects
In this cross-sectional study, we enrolled 119 patients
(62 male, 57 female) with beta -thalassemia major and
intermediate that referred from the hematology clinic
for routine assessment of the liver iron load by MRI
imaging.
The patient’s age ranged from 10 to 50 years with a
mean of 25.6 years.
All of the patients had been received chelation therapy
with subcutaneous deferoxamine. Smokers and patients
with heart failure, previous history of cardiovascular
event, systemic hypertension, diabetes mellitus, hyperli-
pidemia, and thyroid dysfunction were excluded, to
eliminate the effect of these factors on carotid IMT.
The patients based on the compliance, to chelation
therapy had different liver iron load.
Liver iron load was determined by quantitative T2*
MRI technique and the patients based on the severity of
iron loading were divided into three groups: group I
(normal), group II (mild) and group III (moderate and
severe) iron load. Severity of iron loading is defined as
follows:
MRI T2* values greater than 6.3 ms was categorized as
normal (T2* > 6.3 ms), mild (2.8-6.3 ms), moderate (1.4-
2.7 ms) and severe (T2* < 1.4 ms) [23,24].
Mean carotid IMT were assessed in the right and left
common carotid arteries by high-resolution ultrasound in
the mentioned groups. To elimination of the effect of age
in carotid IMT values, the patients also were divided into
four age groups. (10-19 y, 20-29 y, 30-39 y and 40-50 y)
Then mean carotid IMT values based on the liver iron
loading were compared at different age groups.
The Institutional Ethics Committee approved the
study and all subjects gave informed consent.
MRI protocol
MRI scans were performed with a 1.5 T superconduct-
ing MR imager (Siemens Symphony Imager, Erlangen,
Germany), using the method described by Anderson
et al [21].
A standard quadrature RF body coil was used in all
measurements for both excitation and signal detection.
All subjects were placed in a supine position and
entered the magnet cradle, using the head-first config-
uration. Respiratory triggering was used to monitor the
patients’ breathing. Spatial presaturation slabs were used
to suppress motion-related artifacts. The MRI T2* of
the liver was determined using a single 10 mm slice
through the center of the liver scanned at 12 different
echo times (TE 1.3-23 ms).
Each image was acquired during a 11-13 s breath-
hold using a gradient-echo sequence (repetition time
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els, field of view 39.7 × 19.7 cm, sampling bandwidth
of 125 kHz).
The signal intensity of the liver parenchyma and the
background noise were measured in each of the 12
images, using in-house software (CMR tools, Imperial
College). Background noise was subtracted from the
liver signal intensity, and the net value was plotted
against the echo time for each image. A trend line was
fitted to the resulting exponential decay curve, with an
equation of the form y = Ke
TE/T2* where K represents a
constant, TE represents the echo time and y represents
the image signal intensity.
Carotid ultrasound
Longitudinal B-mode scans of the common carotid
artery were obtained, using ALOKA ultrasound system
(model prosound a5 sx, company Ltd, Japan) with
10-MHZ linear array transducer. The gain was set at
60-70 dB that was usual in clinical practice. The far wall
was assessed just 2 cm proximal to the carotid bifurca-
tion, to identify the maximal IMT, by manually.
IMT defined as the distance between the junction of
the lumen and intima and that of the media and adven-
titia [10,25].
Three measurements were made in the right and left
common carotid arteries and were averaged to deter-
mine the IMT for each side.
Statistical analyses
Summary of data are presented as mean values ± one
standard deviation.
The correlations between parameters (liver T2*, IMT,
age) were analyzed, using Pearson’s coefficient of corre-
lation. To compare quantitative variables with different
groups, one way ANOVA analysis were used.
kruskal-wallis analysis also were used, due to relatively
low sample size in this study.
All statistical analyses were assessed using SPSS soft-
ware for windows ver.18 (SPSS Inc., Chicago, IL, USA).
A p-value less than 0.05 was considered statistically
significant.
Results
Table 1 shows summary of general characteristics of the
patients including age, weight, height, age at diagnosis,
transfusion start age, transfusion interval, transfusion
volume, deferoxamine start age and mean duration of
Chelation therapy.
Table 2 shows Pearson’s linear correlation coefficients
for simple regression analysis of the carotid IMT with
the other parameters (age and liver T2*). Age (as a con-
tinuous variable) and liver T2* had significant correla-
tion with mean carotid IMT independently.
Table 3 shows Mean carotid IMT based on the sever-
ity of liver iron loading at different age groups. At the
age group of 10-19 years, no significant differences were
found in mean carotid IMT based on the iron loading.
At the other age groups, mean carotid IMT in group
III (moderate and severe) was higher than group II
(mild) and in group II (mild) was higher than group I
(normal). Differences in mean carotid IMT were signifi-
cant at these age groups based on the iron loading.
With kruskal-wallis analysis, the result was the same
and differences in mean carotid IMT were significant in
all age groups with exception of 10-19 year; with p =
0.5 at 10-19 y, p = 0.004 at 20-29 y, p = 0.006 at 30-39
y and p = 0.021 at 40-50 y.
Figure 1 shows Line chart of the differences in mean
carotid IMT based on the severity of iron loading at dif-
ferent age groups. These differences are lower in the
younger patients and increase with relatively exponential
curve in the older patients.
No significant differences are seen in mean carotid
IMT between male and female. (p = 0.41)
Discussion
Carotid IMT is considered an early marker of athero-
sclerotic process and is currently used to assess the pre-
sence and the progression of atherosclerosis [9,10]. This
study finds an association between iron overload and
early atherosclerosis as reflected by increased carotid
IMT in the thalassemic patients. Our data support the
hypothesis that iron is a risk factor of CHD. Epidemio-
logical studies examining the role of iron in cardiovascu-
lar disease have yielded conflicting results [9,26]. These
conflicting results may due to the use of different
Table 1 General characteristics of the patients
Parameter Mean SD*
Age (year) 25.6 ± 9.2
BMI 20.8 ± 2.9
Age at diagnosis (month) 53 ± 79.1
Transfusion start age (month) 44 ± 66.1
Transfusion volume (ml) 807 ± 216
Transfusion interval (day) 29 ± 24.8
Deferoxamine start age (month) 104 ± 115
Duration of deferoxamine treatment (year) 17 ± 6.3
*SD: standard deviation.
Table 2 Pearson’s correlation coefficients between the
IMT and parameters (age, Liver T2*)
Pearson’s correlation P-value P-value
Age 0.68 0.001
Liver T2* 0.26 0.003
IMT: dependent variable age, Liver T2*: independent variables. P-value < 0.05
is significant.
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factors [9].
Some investigators have hypothesized that iron may
be primarily involved in the early events of athero-
sclerosis, and focusing on cardiovascular morbidity
and mortality (reflecting later stage of the disease)
may not give insight in to the potential mechanistic
role of iron [12,27].
Mentioned reasons explain the failure of some pre-
vious studies to finding an association between body
iron load and CHD.
At the age group of 10-19 years, no significant differ-
ences are seen in mean carotid IMT based on the sever-
ity of iron loading. This finding could be resulting from
this fact that, atherogenesis is a prolonged process[28]
and should not expect to present at early young
patients.
In healthy person’s, carotid IMT is significantly
higher in male in comparison to female [29]. At pre-
sent study there were not significant differences in
Table 3 Mean carotid IMT based on the severity of iron
loading at different age groups
Range of age
(year)
Iron Load Mean
IMT
N* SD” P-value
10-19 Normal 0.49 6 0.02
Mild 0.51 7 0.06 0.661
Moderate &
Severe
0.51 18 0.04
20-29 Normal 0.50 15 0.05
Mild 0.57 17 0.07 0.003
Moderate &
severe
0.59 27 0.08
30-39 Normal 0.53 4 0.04
Mild 0.64 5 0.05 0.006
Moderate &
Sever
0.76 6 0.12
40-50 Normal 0.63 3 0.05
Mild 0.77 5 0.08 0.037
Moderate &
Severe
0.90 6 0.17
*N: number of patients. “SD: standard deviation.
Figure 1 Line chart of the mean carotid IMT based on the severity of iron load.
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in agreement with iron hypothesis. Because in thalasse-
mic patients, body iron load is in the same ranges in
male and female. On opposite, in healthy person’s
body iron load is significantly higher in male in com-
parison to female.
The mechanism by which iron may stimulate athero-
genesis is unclear.
It is suggested that the catalytic role of iron in free
radical reactions cause oxidation of LDL and may be an
important factor in the formation of atherosclerotic
lesions. Studies have shown that iron can stimulate lipid
peroxidation in vitro and in vivo [13].
Iron-catalyzed free radical reactions cause oxidation of
LDL, which occurs in endothelial cells, smooth muscle
cells, lymphocytes, or macrophages.
Normal LDL can cross the arterial wall without causing
damage to the vessel wall. Unlike normal LDL, oxidized
LDL is recognized by macrophages, followed by accumu-
lation of lipids in these cells and the formation of foam
cells, the characteristic cells of the fatty-streak lesions of
early Atherosclerosis. Oxidized LDL also has chemotactic
activity that provides recruitment of circulating mono-
cytes to the vessel wall and prevents the exiting of macro-
phages from the intima of the arterial wall.
Thereby, oxidized LDL has cytotoxic capacity
that induces changes in endothelial cells with loss of
endothelial integrity, which could facilitate further accu-
mulation of both circulating monocytes and LDL and
thus promote the progression of the atherosclerotic
lesion [13,30-33].
Thalassemic patients have mostly blood lipid levels
within the normal range and Prevalence of lipid and
lipoprotein abnormalities is much lower as compared to
the general population of the same age [34], but carotid
IMT is significantly higher in thalassemic patients in
comparison with the healthy persons [35]. This subject
shows the important role of the body iron store in
atherosclerosis process.
The clinical importance of this study is prevention
from the progression of atherosclerosis in early stages
by decrease in body iron load.
Decrease in body iron load can achieve by good com-
pliance of chelation therapy in the thalassemic patients
and by blood donation in healthy persons.
A potential limitation of this study is the cross-sec-
tional and observational nature of our study. This type
of study cannot identify a cause-and-effect relationship,
but associations can be examine. another limitation is
the relative low sample size, especially at the high age
groups.
Findings from the current study may be applied to
thalassemic patients, but cannot be extrapolated directly
to the general population.
Conclusions
In summary, we observed an independent relationship
between body iron load and carotid atherosclerosis. Our
findings are in agreement with previous results and
Support to the hypothesis that iron is linked to cardio-
vascular disease.
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